Tisch MS News

Tisch MSRCNY and Dr. Violaine Harris have been featured in an article in Managed Healthcare Executive about the preliminary analysis of results from our FDA-approved stem cell treatment study. The Q&A highlights the impact of our stem cell research, in particular the potential of our biomarker...

July 13, 2022

More

During the interview, Dr. Sadiq discusses the preliminary analysis of results from our FDA-approved stem cell treatment study and the exciting implications they could have for MS treatment moving forward. He also gives listeners further background on our center and some of the other groundbreaking...

June 29, 2022

More

Tisch MSRCNY, and our FDA-approved stem cell treatment study, have been featured in an article in BioSpace. Drawing from interviews with Dr. Sadiq and Dr. Harris, this piece highlights the great progress that our stem cell treatment research has seen so far, and the tremendous impact we expect the...

June 8, 2022

More

We’re excited to share that one of our patients, Jamie-Lynn Sigler, has been featured in an article in CNN! The piece highlights how Jamie-Lynn navigated her MS journey alongside her career and motherhood – and the invaluable support and care that Dr. Sadiq has provided her along the way. We’re...

June 7, 2022

More

Summer Fridays! In appreciation of our staff's hard work throughout the year, Tisch MSRCNY will be closing at 2:15 PM on Fridays from now until Labor Day weekend.

June 1, 2022

More

In observance of Memorial Day, Tisch MSRCNY will be closing at 1:00 PM 5/27 and will reopen on Tuesday, May 31st at 9 AM. We wish everyone a safe, healthy, and happy holiday!

May 23, 2022

More

Last week our researchers and physicians discussed a paper about the lungs' role in central nervous system autoimmunity. The lungs play a role in central nervous system (CNS) autoimmunity, as smoking and lung infections are risk factors for MS. However, the exact mechanisms for how the lungs affect...

May 11, 2022

More

New Research Finds That, For The First Time Ever, Stem Cell Treatments Improve Disability Status for Multiple Sclerosis Patients With Progressive Disease Preliminary analysis of FDA-approved study conducted by the Tisch MS Research Center of New York found that stem cell treatments substantially...

April 12, 2022

More

Principal Investigators from the Tisch MS Lab recently met to discuss their ongoing investigations. This annual retreat is a way for all of our scientists to present their work and hear feedback from their colleagues, including Dr. Sadiq.

April 5, 2022

More

Tisch MS Research Center News Epstein-Barr Virus and Multiple Sclerosis from Healing MS Spring 2022 Two high-impact papers were published at the beginning of this year that focused on the involvement of Epstein-Barr virus (EBV) infection in multiple sclerosis. For our February 11th Journal Club at...

March 25, 2022

More

Pages

News Archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.